Last reviewed · How we verify
NCT06619821: EASY-PEP
Effects of Parent-Adolescent Joint Interventions for Adolescents With Adverse Childhood Experiences
NA trial testing Emotiaonl skill enhancement in Stress, Emotional in 3,000 participants. Participants enrolled and being followed up; not accepting new ones.
30 April 2025
Quick facts
| Lead sponsor | Peking University |
|---|---|
| Phase | NA |
| Status | Active, enrolled |
| Study type | INTERVENTIONAL |
| Allocation | randomized |
| Design | parallel |
| Masking | single |
| Primary purpose | prevention |
| Enrollment | 3,000 |
| Start date | 27 September 2024 |
| Primary completion | 30 April 2025 |
| Estimated completion | 31 July 2025 |
| Sites | 2 locations across China |
Drugs / interventions tested
- Emotiaonl skill enhancement
- PCE promotion
- Psychoeducation
Conditions studied
- Stress, Emotional — all drugs for Stress, Emotional →
- Stress-related Mental Disorders — all drugs for Stress-related Mental Disorders →
- Adverse Childhood Experiences — all drugs for Adverse Childhood Experiences →
Sponsor
Peking University
Who can join
Adults 10 to 18, any sex, with Stress, Emotional or Stress-related Mental Disorders. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The study aims to examine the effectiveness of joint parent-adolescent intervention in improving the mental health outcomes of participants, specifically by reducing symptoms of depression, anxiety, and PTSD, as measured by the Patient Health Questionnaire (PHQ-9), the Generalized Anxiety Disorder-7 scale (GAD-7), and the Child PTSD Symptom Scale for DSM-5 (CPSS-5). Adolescents will be recruited from middle schools and randomly assigned to one of three groups: (a) psychoeducation, (b) psychoeducation + emotional skills enhancement, or (c) psychoeducation + emotional skills enhancement + positive childhood experience promotion. The school-based intervention will consist of 4-8 sessions, with assessments conducted at baseline, post-treatment, and a 3-month follow-up. Investigators will conduct multilevel models (MLMs) and structural equation models (SEMs) to investigate the impact of Adverse Childhood Experiences (ACEs), Positive Childhood Experiences (PCEs), alexithymia, and emotion regulation abilities on mental health outcomes in adolescents.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT06619821
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Emotiaonl skill enhancement
Trials testing the same drug.
- NCT06650696 — Effects of Parent-Adolescent Joint I-Interventions for Adolescents with Adverse Childhood Experiences · NA · active not recruiting
Other recruiting trials for Stress, Emotional
Currently open trials in the same condition.
- NCT07115186 — School-Based Intervention to Enhance Resilience and Stress Coping in Rural Chinese Adolescents · NA · recruiting
- NCT06899308 — Health Surveillance at Constructor University Bremen (CUB) and Among HAW-Hamburg Employees · recruiting
- NCT06650696 — Effects of Parent-Adolescent Joint I-Interventions for Adolescents with Adverse Childhood Experiences · NA · active not recruiting
- NCT05092542 — Intervention to Address Disparate Mental Health Consequences of COVID-19 Pandemic on Latinx and African Newcomers · NA · active not recruiting
- NCT03412162 — Biology, Identity & Opportunity Study · NA · active not recruiting
Other Peking University trials
Trials by the same sponsor.
- NCT07519122 — Fangshan Active Nutrition Initiative · NA · not yet recruiting
- NCT07466238 — HAIC Plus Systemic Therapy as De-escalation Therapy Strategy for Biliary Tract Cancer · NA · recruiting
- NCT07480525 — Efficacy and Mechanisms of Escitalopram in Drug-Naïve First-Episode Major Depressive Disorder · NA · not yet recruiting
- NCT07454031 — Intraperitoneal PX in Combination With Nab-Paclitaxel in Patients With Peritoneal Metastatic Mucinous Adenocarcinoma · Phase 1 · not yet recruiting
- NCT07466225 — HAIC Plus Lenva and PD-1 for Advanced HCC With Macrovascular or Biliary Invasion · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06619821 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Peking University
- Last refreshed: 4 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06619821.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing